- Investing.com
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Analyst Optimism | Learn about OptimizeRx's market potential, with analyst price targets ranging from $8 to $20, reflecting varied outlooks on the company's growth trajectory |
Strategic Crossroads | Delve into OptimizeRx's shift towards subscription-based revenue and potential strategic alternatives, including a sale, amidst scaling challenges |
Financial Momentum | Explore OptimizeRx's impressive Q2 2025 results, with revenue soaring 55% year-over-year and EBITDA margins expanding significantly to 19.7% |
Digital Health Pionee | OptimizeRx leads in healthcare provider marketing, leveraging deep EHR integration for pharmaceutical messaging and showcasing strong financial growth |
Metrics to compare | OPRX | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipOPRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 6,535.2x | −0.8x | −0.6x | |
PEG Ratio | 65.26 | 0.03 | 0.00 | |
Price / Book | 1.8x | 1.3x | 2.6x | |
Price / LTM Sales | 2.0x | 1.4x | 3.4x | |
Upside (Analyst Target) | 101.3% | 60.8% | 41.5% | |
Fair Value Upside | Unlock | 32.7% | 4.4% | Unlock |